Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis.

Varma, Devika M; Redding, Elizabeth A; Bachelder, Eric M; Ainslie, Kristy M

Varma, Devika M; Redding, Elizabeth A; Bachelder, Eric M; Ainslie, Kristy M.

Afiliação

Varma DM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Redding EA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ACS Biomater Sci Eng ; 7(5): 1725-1741, 2021 05 10.

Article em En | MEDLINE | ID: mdl-33966377

Assuntos

Leishmania donovani; Leishmania infantum; Leishmaniose Visceral; Sistemas de Liberação de Medicamentos; Humanos; Leishmaniose Visceral/tratamento farmacológico

Palavras-chave

Leishmania donovani; Leishmania infantum; emulsions; liposomes; micelles; nanoparticles; polymeric particles; polymersomes; visceral leishmaniasis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leishmania donovani / Leishmania infantum / Leishmaniose Visceral Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Biomater Sci Eng Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google